about
Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugsComprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status.Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FuturePayers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysA Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UKThe transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland.Price comparison of high-cost originator medicines in European countries.Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.Editorial: Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies.Quality indicators as a tool in improving the introduction of new medicines.Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR.Addressing challenges for sustainable healthcare in Central and Eastern Europe.Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States
P2860
Q28468294-80255948-7DA2-406E-8D41-C7AE67A551DAQ33730376-BBDD9DCB-0B83-4078-BBEB-3AD8BF884CEEQ33806813-A92CCF40-B11A-48A9-AF7A-64B3368DABA1Q37135584-0184E820-C1AA-4001-A7B2-63C9F8EA58CEQ37290101-650F9711-5A8E-4AC0-8D38-0F92F6C7BFF0Q37710138-66642D0B-6239-4186-80CD-0DA00181FB63Q38791269-588EA6CF-6036-46D8-BFF2-B0D4E5AE22D6Q39362176-32BDADE6-2F9A-476F-8C7D-A7EA39C601E8Q41526451-8523140A-7061-41D9-A3BF-112CEEA2E966Q42363814-9A4F6C54-EE5A-44F7-98CF-DEFB0228C27AQ44695835-251A4F78-BCC6-4C27-A4DF-EF8AA7505C62Q48131623-E0240FF2-FA8C-4718-8867-111ECCF034CBQ48850279-6B2D384F-2948-4BB5-BB8F-48CFA1FF82B0Q58795676-69C67054-36FC-42BB-A9C8-CF465500E77D
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Are payers treating orphan drugs differently?
@en
type
label
Are payers treating orphan drugs differently?
@en
prefLabel
Are payers treating orphan drugs differently?
@en
P2860
P356
P1476
Are payers treating orphan drugs differently?
@en
P2093
Abigail Felix
Joshua P Cohen
P2860
P356
10.3402/JMAHP.V2.23513
P577
2014-01-15T00:00:00Z